Peripheral Artery Disease - General

Semaglutide Improves PAD Outcomes Regardless of Sex

Radcliffe CVRM

TCT 25: LIFE-BTK: The Esprit™ BTK Drug-Eluting Resorbable Scaffold for Infrapopliteal Lesions

Sahil Parikh

Watch time: 5m 49s
Paclitaxel-Coated Devices Do Not Reduce Amputation Risk in Chronic Limb-Threatening Ischaemia

Radcliffe Vascular

SWEDEPAD 1: Paclitaxel-Coated Devices Show No Benefit in Reducing Amputation for CLTI

Transcatheter Academy

ESC 25: STRIDE: Outcomes by Sex

Subodh Verma

Watch time: 8m 9s
ESC 25: SWEDEPAD 1 and 2

Marten Falkenberg, Joakim Nordanstig

Watch time: 6m 35s
GLP-1 Medications for Patients with Moderate Peripheral Artery Disease

Catherine Go

Watch time: 3m 12s
The MOTIV Trial: 3-Year Results

Watch time: 5m 3s
ACC 25 Late-Breaking Discussion: The STRIDE Trial

Harriette Van Spall, Marc P Bonaca

Watch time: 11m 44s
ISET 25: Drug Delivery Devices: Paclitaxel Drug-Coated Balloons and Drug-Eluting Stents

Marianne Brodmann

Watch time: 4m 5s
LINC 25: The PATCH Study

Sean Lyden

Watch time: 3m 15s
ABSORB: Final Outcomes With the Absorb Bioresorbable Vascular Scaffold

David Power

Watch time: 6m 52s

Rifly Rafiudeen, Peter Barlis, Harvey D White, et al

Read time: 15m 34s

Giuseppe Ferrante, Brittany A Bacallao, Francesco Gioia, et al

Read time: 5m 38s
TCT 25: LIFE-BTK: The Esprit™ BTK Drug-Eluting Resorbable Scaffold for Infrapopliteal Lesions

Sahil Parikh

Watch time: 5m 49s
ESC 25: STRIDE: Outcomes by Sex

Subodh Verma

Watch time: 8m 9s

Brock Cookman, Suhail Allaqaband, Tonga Nfor

Read time: 17m

Jimmy Kerrigan, Timir K Paul, Jay Patel, et al

Read time: 18m
HFA 23: Dapagliflozin and PAD in HF

Jawad Haider Butt

Watch time: 3m 50s
ESC 25: SWEDEPAD 1 and 2

Marten Falkenberg, Joakim Nordanstig

Watch time: 6m 35s
Semaglutide Improves PAD Outcomes Regardless of Sex

Radcliffe CVRM

ABSORB: Final Outcomes With the Absorb Bioresorbable Vascular Scaffold

David Power

Watch time: 6m 52s
LINC 25: The PATCH Study

Sean Lyden

Watch time: 3m 15s
Paclitaxel-Coated Devices Do Not Reduce Amputation Risk in Chronic Limb-Threatening Ischaemia

Radcliffe Vascular

Media

ISET 25: Drug Delivery Devices: Paclitaxel Drug-Coated Balloons and Drug-Eluting Stents

Marianne Brodmann

Watch time: 4m 5s
LINC 25: The PATCH Study

Sean Lyden

Watch time: 3m 15s
ABSORB: Final Outcomes With the Absorb Bioresorbable Vascular Scaffold

David Power

Watch time: 6m 52s
LINC 2025: 12-Month Amputation and Readmission Rates from TRUE-PTX

Marianne Brodmann

Watch time: 3m 41s
LINC 25: The GRIFFIN Study

Tatsuya Nakama

Watch time: 11m 59s
TCT 25: LIFE-BTK: The Esprit™ BTK Drug-Eluting Resorbable Scaffold for Infrapopliteal Lesions

Sahil Parikh

Watch time: 5m 49s
ESC 25: STRIDE: Outcomes by Sex

Subodh Verma

Watch time: 8m 9s
ESC 25: SWEDEPAD 1 and 2

Marten Falkenberg, Joakim Nordanstig

Watch time: 6m 35s
GLP-1 Medications for Patients with Moderate Peripheral Artery Disease

Catherine Go

Watch time: 3m 12s
VOYAGER PAD: Rivaroxaban in Symptomatic PAD With & Without Comorbid Diabete

Cecilia Low Wang

Watch time: 6m 9s
ACC 22: Results From the Chocolate-Touch Study

Mehdi Shishehbor

Watch time: 5m 41s
TCT 23: 5 Trials That Will Change My Practice

Bernardo Cortese

Watch time: 12m 36s

Articles

Commentary 2024 ESC Guidelines on Peripheral Arterial and Aortic Diseases

Giuseppe Ferrante

,

Brittany A Bacallao

,

Francesco Gioia

,

Guido Del Monaco

,

Francesco Amata

,

Published:

29 November 2024

Citation:

European Cardiology Review 2024;19:e24.

DOI:

https://doi.org/10.15420/ecr.2024.45
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 426
  • Downloads: Downloads 116
  • Read time: 5m 38s

Mid-term Follow-up of Arch Vessel Angioplasty in Takayasu Arteritis

Avishek Bagchi

,

Sanjay Tyagi

,

Ankit Bansal

,

Mohit D Gupta

,

Girish MP

,

Published:

28 November 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023;2:e42.

DOI:

https://doi.org/10.15420/japsc.2023.08
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 203
  • Downloads: Downloads 25
  • Read time: 18m

Vascular Access Management of Complex High Risk Interventional Procedures

Jimmy Kerrigan

,

Timir K Paul

,

Jay Patel

,

Walid Saad

,

Andrew Morse

,

Elias Haddad

,

Angel Chandler

,

Jonathan Emling

,

Hady Lichaa

,

Published:

20 October 2023

Citation:

US Cardiology Review 2023;17:e16.

DOI:

https://doi.org/10.15420/usc.2023.04
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1675
  • Downloads: Downloads 140
  • Citations: 2
  • Read time: 18m

Type 2 MI and Myocardial Injury in the Era of High-sensitivity Troponin

Rifly Rafiudeen

,

Peter Barlis

,

Harvey D White

,

William van Gaal

,

Published:

17 February 2022

Citation:

European Cardiology Review 2022;17:e03.

DOI:

https://doi.org/10.15420/ecr.2021.42
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 5429
  • Downloads: Downloads 289
  • Citations: 14
  • Read time: 15m 34s